Table 1.

Characteristics of HL patients and controls, and lymphomas in the Scandinavian case-control study

Characteristics of HL patients and controls
Cases (%)Controls (%)
Overall5863,187
Country
    Denmark247 (42.2)1,186 (37.2)
    Sweden339 (57.8)2,001 (62.8)
Gender
    Female280 (47.8)1,420 (44.6)
    Male306 (52.2)1,767 (55.4)
Age group (y)
    18–24104 (17.7)123 (3.9)
    25–34174 (29.7)189 (5.9)
    35–44107 (18.3)264 (8.3)
    45–5464 (10.9)597 (18.7)
    55–6470 (11.9)906 (28.4)
    65–7467 (11.5)1,108 (34.8)
Lymphoma EBV status
Positive (%) *Negative (%) *Missing
Overall142 (28.5)357 (71.5)87
Women51 (21.2)190 (78.8)39
Men91 (35.3)167 (64.7)48
Country
    Denmark64 (30.8)144 (69.2)39
    Sweden78 (26.8)213 (73.2)48
Subtype
    Mixed cellularity44 (50)44 (50)14
    Nodular sclerosis80 (22.4)277 (77.6)53
    Other or undefined18 (33.3)36 (66.7)20
Age group (y)
    18–2421 (23.1)70 (76.9)13
    25–3437 (24.7)113 (75.3)24
    35–4427 (27.8)70 (72.2)10
    45–5410 (19.2)42 (80.8)12
    55–6421 (35.6)38 (64.4)11
    65–7426 (52.0)24 (48.0)17
  • NOTE: Percentages may not add up to 100 because of rounding.

  • * Percent of tumors with known EBV status by row.

  • Includes seven cases with indeterminable EBV status.